Optimal Combinations of CellGenix^® Reagents Boost Natural Killer Cell Expansion, Viability, and Purity

Cell and gene therapies are revolutionizing medicine—and NK cell therapy is leading the charge. As clinical programs scale, sourcing GMP-grade raw materials that support robust expansion and cytotoxic function of NK cells becomes mission-critical. 

CellGenix^® GMP SCGM and Recombinant Human Cytokines (IL-2, IL-12, IL-18, IL-21) provide a high-performance, xeno-free solution for NK cell expansion and activation. Backed by GMP-grade quality and aligned with USP <1043> and ISO 20399:2022, they offer:

• High NK cell yield
• Preserved cytotoxic activity
• Proven safety and compliance

See how CellGenix^® SCGM and cytokines outperformed other media in our latest application note.